• 1
    Carr DJ. Opioid receptors on cells of the immune system. Prog Neuroendocr Immunol 1989; 2: 814.
  • 2
    Castro GA. Immunological regulation of electrolyte transport. In: Lebenthal E, Duffey M, eds. Textbook of Secretory Diarrhoea. New York: Raven Press 1990:31–45.
  • 3
    Blennerhasset MG, Vignjevic P, Vermillion DL. Collins SM. Inflammation causes hyperplasia and hypertrophy in smooth muscle of rat small intestine. Am J Physiol 1992; 262:G10416.
  • 4
    Castro GA, Powell DW. The physiology of the mucosal immune system and immune-mediated responses in the gastrointestinal tract. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York: Raven Press 1994:709–50.
  • 5
    Wakefield AJ, Sawyerr AFM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2: 105762.
  • 6
    Morson BC, Dawson IMP. Gastrointestinal Pathology, 2nd edn. Oxford: Blackwell Scientific Publications Ltd; 1979.
  • 7
    Collins SM. The immunomodulation of enteric neuromuscular function; implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 16839.
  • 8
    Ibba-Manneschi L, Martini M, Zecchi-Orlandini S, Faussone-Pellegrine MS. Structural organization of enteric nervous system in human colon. Histol Histopathol 1995; 10: 1725.
  • 9
    Christensen J. The enteric nervous system. In: Kumar D, Gustavsson S, eds. An Illustrated guide to Gastrointestinal Motility. Chichester: John Wiley & Sons 1988;9–31.
  • 10
    Dhatt N, Buchan AMJ. Colocalization of neuropeptides with calbindin D28k and NADPH Diaphorase in the enteric nerve plexuses of normal human ileum. Gastroenterology 1994; 107: 68090.
  • 11
    Hoyle CHV, Burnstock G. Neuronal populations in the submucous plexus of the human colon. J Anat 1989; 166: 722.
  • 12
    Belai A, Boulos PB, Robson T, Burnstock G. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut 1997; 40: 76774.
  • 13
    Driessen A, Creemers J, Geboes K. Anti-Leu 19 is a marker for nervous tissue in the mucosa of the human rectum. Acta Anat 1995; 153: 12734.
  • 14
    Matini P, Faussone-Pelligrini MS, Cortesini C, Mayer B. Vasoactive intestinal polypeptide and nitric oxide synthase distribution in the enteric plexuses of the human colon: an immunohistochemical study and quantitative analysis. Histochem Cell Biol 1995; 103: 41523.
  • 15
    Nichols K, Staines W, Wu JY, Krantis A. Immunopositive GABAergic neural sites display nitric oxide synthase- related NADPH diaphorase activity in the human colon. J Auton Nerv Syst 1995; 50: 25362.
  • 16
    Krammer HJ, Zhang M, Kuhnel W. Distribution of NADPH-diaphorase-positive neurons in the enteric nervous system. Anat Anz 1994; 176: 13741.
  • 17
    Hirata I, Berrebi G, Austin LL, Keren DF, Dobbins WO. Immunohistochemical characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon in inflammatory bowel disease. Dig Dis Sci 1986; 31: 593603.
  • 18
    Ruhl A, Collins SM. Enteroglial cells are an integral part of the neuroimmune axis in the gut. Gastroenterology 1995; 108:A650.
  • 19
    Hoehner JC, Wester T, Pahlman S, Olsen L. Localization of neurotrophins and their high-affinity receptors during human enteric nervous system development. Gastroenterology 1996; 110: 75667.
  • 20
    Bandtlow CF, Heumann R, Schwab ME, Thoenen H. Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO 1987; 6: 8919.
  • 21
    Thompson SJ, Schatteman GC, Gown AM, Bothwell M. A monoclonal antibody against Nerve Growth Factor receptor. Am J Clin Pathol 1989; 92: 41523.
  • 22
    Musch MW, Chang EB. Diarrhea in Inflammatory Bowel Disease. In: Targan S, Shanahan F, eds. Inflammatory Bowel Disease From Bench to Bedside. Baltimore: Williams and Wilkins 1993: 239–54.
  • 23
    Farthing MJG, Lennard-Jones JE. Sensitivity of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut 1978; 19: 649.
  • 24
    Kern FJ, Almy TP, Abbot FK, Bogdonoff MD. Motility of the distal colon in nonspecific ulcerative colitis. Gastroenterology 1951; 19: 492503.
  • 25
    Reddy SN, Bazocchi G, Chan S, et al.Colonic motility and transit in health and ulcerative colitis. Gastroenterology 1991; 101: 128997.
  • 26
    Snape WJ. The role of colonic motility disturbance in ulcerative colitis. Keio J Med 1991; 40: 68.
  • 27
    Rao SS, Read NW. Gastrointestinal motility in patients with ulcerative colitis. Scand J Gastroenterol Suppl 1990; 172: 228.
  • 28
    Annese V, Bassotti G, Napolitano G, et al. Most patients with inactive Crohn's disease have gastrointestinal motility disorders. Gastroenterology 1993; 104:A470.
  • 29
    Vermillion DL, Huizinga JD, Riddell RH, Collins SM. Altered small intestinal smooth muscle function in Crohn's disease. Gastroenterology 1993; 104: 16929.
  • 30
    Lindgren S, Stewenius J, Sjölund K, Lilja B, Sundkvist G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol 1993; 28: 63842.
  • 31
    Lindgren S, Lilja B, Rosën I, Sundkvist G. Disturbed autonomic nerve function in patients with Crohn's disease. Scand J Gastroenterol 1991; 26: 3616.
  • 32
    Bogers JJ, Pelckmans PA, Van Marck EA. Veranderingen in het innervatiepatroon van de darm na infectie met Schistosoma mansoni. Tijdschr Gastroenterol 1994; 26: 1622.
  • 33
    Crohn BB, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. J Am Med Assoc 1932; 99: 13239.
  • 34
    Haferkamp O. Uber die produktive entzündung bei der enteritis regionalis (Crohn). Beitr pathol Anat 1959; 121: 2738.
  • 35
    Antonius JL, Gump FE, Lattes R, Lepore M. A study of certain microscopic features in regional enteritis, and their possible prognostic significance. Gastroenterology 1960; 38: 889905.
  • 36
    Mottet NK. Histopathologic Spectrum of Regional Enteritis and Ulcerative Colitis. Philadelphia: W.B. Saunders Company 1971: p. 143.
  • 37
    Strobach RS, Ross A, Markin RS, Zetterman RK, Linder J. Neural patterns in inflammatory bowel disease: an immunohistochemical survey. Modern Pathol 1990; 3: 48893.
  • 38
    Geboes K, Rutgeerts P, Penninckx F, Desmet V, Vantrappen G. The destruction of the autonomic nervous system in Crohn's disease is due to immunologic effector cells. Gastroenterology 1989; 96:A168.
  • 39
    Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989; 97: 57585.
  • 40
    Riemann JF, Schmidt H. Ultrastructural changes in the gut autonomic nervous system following laxative abuse and in other conditions. In: Polak JM, Bloom SR, Wright NA, Daly MJ, eds. Basic Science in Gastroenterology: Structure of the Gut. Ware, Herts: Glaxo Group Research Ltd 1982: 289–302.
  • 41
    Geboes K. Immunopathological studies on the small intestinal intramural nervous system and of intramural vessels in Crohn's disease. Verh K acad geneeskd Belg 1993; 55: 267303.
  • 42
    Nadorra R, Landing BH, Wells TR. Intestinal plexuses in Crohn's disease and ulcerative colitis in children: pathologic and microdissection studies. Pediatr Pathol 1986; 6: 26787.
  • 43
    Cook MG, Dixon MF. An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut 1973; 14: 25562.
  • 44
    Dvorak AM, Osage JE, Monahan RA, Dickersin GR. Crohn's disease: transmission electron microscopic studies. III. Target tissues proliferation of and injury to smooth muscle and the autonomic nervous system. Hum Pathol 1980; 11: 62034.
  • 45
    Dvorak AM. Ultrastructural pathology of Crohn's disease. In: Goebell H, Peskar BM, Malchow H, eds. Inflammatory Bowel Diseases. Lancaster, Boston: MTP Press Ltd 1988: 3–42.
  • 46
    Steinhoff MM, Kodner IJ, De Schryver-Keckskemeti K. Axonal degeneration/necrosis: a possible ultrastructural marker for Crohn's disease. Mod Pathol 1988; 1: 1827.
  • 47
    Dvorak AM, Silen W. Differentiation between Crohn's disease and other inflammatory conditions by electronmicroscopy. Ann Surg 1985; 201: 5363.
  • 48
    Brewer DB, Thompson H, Haynes IG, Alexander-Williams J. Axonal damage in Crohn's disease is frequent but not specific. J Pathol 1990; 161: 30111.
  • 49
    Earlam RJ. Ganglion cell changes in experimental stenosis of the gut. Gut 1971; 12: 3938.
  • 50
    Von Herbay A, Castrucci M, Otten U, Otto HF. Coexpression of nerve growth factor receptor and cytokine receptor CD27 in enteric neurons and immune cells in ulcerative colitis and Crohn's disease. Gastroenterology 1993; 104:A797.
  • 51
    Siemers PT, Dobbins W. The Meissner plexus in Crohn's disease of the colon. Surg Gynecol Obstet 1974; 138: 3942.
  • 52
    Van Patter WN, Bargen JA, Dockerty MC, Feldmann WH, Mayo CW, Waugh JM. Regional enteritis. Gastroenterology 1954; 26: 34751.
  • 53
    Davis DR, Dockerty MB, Mayo CW. The myenteric plexus in regional enteritis: a study of the number of ganglion cells in the ileum in 24 cases. Surg Gynecol Obstet 1955; 101: 20816.
  • 54
    Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 1980; 79: 85360.
  • 55
    Storsteen KA, Kernohan JW, Bargen JA. The myenteric plexus in chronic ulcerative colitis. Surg Gynecol Obstet 1953; 97: 33543.
  • 56
    Okamoto E. Morphological studies on the myenteric plexus of the colon in chronic ulcerative colitis: a preliminary report. Med J Osaka Univ 1964; 15: 85106.
  • 57
    Oehmichen M, Reiffersscheid P. Intramural ganglion cell degeneration in inflammatory bowel disease. Digestion 1977; 15: 48296.
  • 58
    Van der Zypen E. Light and electron microscopic findings on the autonomic nervous system of the colon in human ulcerative colitis. Dtsch Z Nervenheilk 1965; 187: 787836.
  • 59
    Geboes K, Mebis J, Rutgeerts P, Ectors N, Vantrappen G. Demonstration of nitric oxide positive neurons in Crohn's disease. Gastroenterology 1993; 104:A705.
  • 60
    O'Morain CO, Bishop AE, McGregor GP, et al. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease, Gut 1984; 25: 5761.
  • 61
    Sjolund K, Schaffalitzky OB, Muckadell DE, et al.Peptide-containing nerve fibers in the gut wall in Crohn's disease. Gut 1983; 24: 72433.
  • 62
    Kubota Y, Petras RE, Ottaway CA, Tubbs RR, Farmer RG, Fiocchi C. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. Gastroenterology 1992; 102: 124251.
  • 63
    Kubota Y, Petras RE, Tubbs RR, Farmer RG, Fiocchi C, Ottaway CA. Loss of vasoactive intestinal peptide (VIP) immunoreactive nerve fibres in the colon of IBD patients. In: Tsuchiya M, Nagura H, Hibi T, Moro I, eds. Frontiers of Mucosal Immunology. Amsterdam: Excerpta Medica 1991:843–6.
  • 64
    Ottaway CA, Lewis DL, Asa SL. Vasoactive intestinal peptide-containing nerves in Peyer's patches. Brain, Behav Immunity 1987; 1: 15972.
  • 65
    Geboes K, Rutgeerts P, Ectors N, et al.Major Histocompatibility Class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology 1992; 103: 43947.
  • 66
    Koretz K, Momburg F, Otto HF, Moller P. Sequential induction of MHC antigens on autochtonous cells of ileum affected by Crohn's disease. Am J Pathol 1987; 129: 493502.
  • 67
    Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis. Lancet 1982; 2:555.
  • 68
    Minuk GY, Lewkonia RM. Possible familial association of multiple sclerosis and inflammatory bowel disease. N Engl J Med 1986; 314:586.
  • 69
    Vinals M, Anciones B, Cruz-Martinez A, Barreiro P. Sindrome de Miller-Fisher recidivante asociado a neuritis braquial. Neurologia 1989; 4: 615.
  • 70
    Geissler A, Andus T, Roth M, et al.Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995; 345: 8978.
  • 71
    Hart PE, Gould SR, Jones L, et al.Brain white matter lesions in inflammatory bowel disease. Gut 1997; 41 (Suppl. 3), A118.
  • 72
    McHugh KJ, Weingarten HP, Keenan C, Wallace JL, Collins SM. On the suppression of food intake in experimental models of colitis in the rat. Am J Physiol 1993; 264:R8716.
  • 73
    Mapp PI, Walsh DA, Garrett NE, et al. Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis 1994; 53: 2406.
  • 74
    Eysselein VE, Reinshagen M, Patel A, Davis W, Nast C, Sternini C. Calcitonin gene-related peptide in inflammatory bowel disease and experimentally induced colitis. Ann NY Acad Sci 1992; 657: 31927.
  • 75
    Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795803.
  • 76
    Rachmilewitz D, Okon E, Karmeli F. Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn's disease. Gut 1997; 41: 35865.
  • 77
    Stead RH. Nerve remodelling during intestinal inflammation. Ann NY Acad Sci 1992; 664: 44355.
  • 78
    Geboes K, Rutgeerts P, Ectors N, Mebis J, Desmet V, Vantrappen G. Are section margins useful for the prediction of recurrence of Crohn's disease after all? Gastroenterology 1990; 98:A171.
  • 79
    Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 66572.
  • 80
    Geboes K, Rutgeerts P. Vasculitis and Crohn's disease. Res Clin Forums 1995; 17: 5765.
  • 81
    Geller SA, Cohen A. Arterial inflammatory cell infiltration in Crohn's disease. Arch Pathol Lab Med 1983; 107: 4735.
  • 82
    Wakefield AJ, Sankey EA, Dhillon AP, et al.Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991; 100: 127987.
  • 83
    Birch DJ, Belai A, Boulos PB, Burnstock G.Human perivascular innervation in inflammatory bowel disease (IB): a confocal study. Gut 1997; 41 (Suppl. 3), A11.
  • 84
    Kannan Y, Stead RH, Goldsmith CH, Bienenstock J. Lymphoid tissues induce NGF-dependent and NGF-independent neurite outgrowth from rat superior cervical ganglia explants in culture. J Neurosci Res 1994; 37: 37483.
  • 85
    Eysselein VE. Neuropeptides and inflammatory bowel disease. Z Gastroenterol 1991; 26: 2537.
  • 86
    Roberts PF, Stebbings WSL, Kennedy HJ. Granulomatous visceral neuropathy of the colon with non-small cell lung carcinoma. Histopathology 1997; 30: 58891.
  • 87
    Debinski HS, Kamm MA, Talbot IC, Khan G, Kangro HO, Jeffries DJ. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut 1997; 41: 1006.
  • 88
    Ekbom A, Aami HO, Helmick CG, Jonzon A, Zack MM. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990; 132: 11119.
  • 89
    Lewin J, Dhillon AP, Sim R, Mazure G, Pounder RE, Wakefield AJ. Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut 1995; 36: 5649.